INTRODUCTION
Intracerebral injection of the temperature-sensitive mutant tsG31 (III) of vesicular stomatitis virus (VSV) into mice results in an unusual pathological response in the central nervous system (CNS). By 4 days after infection a marked status spongiosus develops in the grey matter of the spinal cord (Dal Canto et al., 1976) . The mice exhibit hind limb paralysis after 3 or 4 days of infection and die after 7 or 8 days, which is quite unlike the results of an intracerebral injection with wild-type (wt) VSV, where the mice die in 1 or 2 days without paralysis and with minimal pathological changes in the CNS (Dal Canto et al., 1976; Rabinowitz et al., 1977) .
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The ts G31 (III) mutant is a matrix (M) protein mutant belonging to VSV genetic complementation group III (Pringle, 1970) . The ts G31 (III) mutant synthesizes all the virus proteins at the non-permissive temperature of 39 °C but the M protein rapidly degrades and no infectious virus matures from the infected cells (Hughes et al., 1979 b) .
In addition to causing a marked status spongiosus in the CNS of the mouse, the ts G31 (III) mutant also induces extensive cell fusion of mouse neuroblastoma cells in vitro (Hughes et al., 1979a) . Cell fusion has only been shown with nervous system-derived cells during a non-permissive infection (Hughes et al., 1979a; DiIle et al., 1982) . The fusion requires the synthesis and expression of the VSV glycoprotein (G) on the infected cell surface membrane and is inhibited by the addition of glucosamine or tunicamycin that interfere with glycosylation (Hughes et al., 1979 a, Dille et al., 1981 .
Chloroquine, a quinoline derivative, has been used for a number of years as an anti-malarial drug, although its mode of action at the molecular level remains unclear. The inhibitory activity of chloroquine has been thought to be related to its ability to accumulate in cell lysosomes, altering the pH of these subcellular organdies (Ohkuma & Poole, 1978) and thereby leading to the inactivation of lysosomal function (Lie & Schofield, 1973; Matsuzawa & Hostetler, 1980; Weissmann, 1964) . However, chloroquine also binds to DNA, RNA and proteins (Ciak & Hahn, 1966) , and it can inhibit both DNA and RNA synthesis (Cohen & Yielding, 1965) .
The use of chloroquine to study virus replication has led to a variety of observations. It has been reported that chloroquine has no inhibitory action on Newcastle disease virus (NDV) replication (Wilson, 1972) , whereas the presence of the driag stimulates Epstein-Barr virus growth (Karmali et al., 1978) , and inhibits replication of Semliki Forest virus (Helenius et al., 1980) and herpes simplex virus (Lancz et al., 1971) . Durand et al. (1971) demonstrated that NDV replication had a bimodal and concentration-dependent response to chloroquine. Low concentrations (0.0025 gg/ml) and high concentrations (250 gg/ml) of chloroquine stimulated NDV replication while intermediate concentations (0.25 to 25 /~g/ml) reduced virus yields. Most studies of the antiviral action of chloroquine have focused on the initial stages of infection. For instance, Durand et al. (1971) found the same bimodal response of NDV uncoating as that observed by measuring virus yields. An extensive study with Semliki Forest virus suggested that the lysosomes play an important role in uncoating the virions (Helenius et al., 1980) and a similar observation with VSV suggested that the initial uncoating of the virions is inhibited when lysosomal enzymes are inhibited by chloroquine (Miller & Lenard, 1980) . Another study with VSV showed that 25 to 50 gg/ml chloroquine inhibited virus RNA synthesis even when the drug was added after the initial stage of uncoating was completed (Shimizu et al., 1972) . However, in that study no attempt was made to determine whether the inhibition was primarily associated with VSV messenger RNA synthesis or the replication of negative RNA strands. Whether chloroquine inhibits VSV protein synthesis or later stages in virion maturation, therefore, is presently unknown.
The present study was carried out to elucidate the reason for the ability of chloroquine to inhibit cell fusion. We conclude that chloroquine has an inhibitory action against later steps in virus maturation by inhibiting the expression of the VSV G protein at the cell surface.
METHODS
Cell culture and viruses. Mouse neuroblastoma N-18 cells were grown in F-12 medium supplemented with 5 % foetal calf serum and 5 % newborn calf serum, NaHCO 3, antibiotics, and 2 x amino acids as described previously (Hughes et al., 1979 a) . The Indiana strain of wt VSV was obtained from the American Type Culture Collection (Rockville, Md., U.S.A.), and ts G31 (III) (Pringle, 1970) was kindly provided by M. E. Reichmann (University of Illinois, Urbana, Ill., U.S.A.). All viruses were plaque-purified and stocks were prepared as described previously (Hughes et al., 1979 a) . Medium components were purchased from Grand Island Biological Co. (Grand Island, N.Y., U.S.A.) .
Virus growth assay. N-18 cells (2 × l0 s cells/culture tube) were infected with wt VSV at an m.o.i, of 10. The virus was allowed to adsorb for 30 min at 25 °C, the cells were washed three times with Hanks' balanced salt solution (HBSS) to remove unadsorbed virus, and F-12 medium was then added. One set of nine cultures received only F-12 medium, while three other sets of cultures received F-12 medium and 50 ~tg/ml chloroquine diphosphate (100 pM) (Sigma) 1 h before infection, 1 h post-infection and 2 h post-infection respectively. Three tubes from each set were immediately stored at -80 °C to provide measurements of the original virus titres. The remaining tubes were placed in a 39 °C water bath; at 12 h and 24 h post-infection three tubes from each set were removed and frozen at -80 °C. Plaque assays were performed as described previously (Holland & McLaren, 1959) .
Indirect immunofluorescence. Antiserum to the VSV G protein was prepared as described previously (Hughes et al., 1979 a) and the IgG fraction was purified by ammonium sulphate precipitation, dialysis and DEAE column chromatography (Fahey & Terry, 1978; Heide & Schwick, 1978) . N-18 cells were grown on 484 mm 2 coverslips, subconfluent monolayers were infected with ts G31 (III) at an m.o.i, of 10, and incubated at 39 °C. Cells were either left untreated, or pretreated 1 h before infection with 50 gg/ml chloroquine, or treated with 50 /~g/ml chloroquine 1 h or 2 h post-infection. At 24 h post-infection, the cells on the coverslips were fixed in 3.7% formaldehyde in phosphate-buffered saline (PBS) at 25 °C for 10 min or in acetone :methanol (2:1, v/v) at -20 °C for 10 min. Indirect immunofluorescence was performed with anti-G protein antibody followed by fluorescein isothiocyanate-labelled goat IgG prepared against rabbit IgG (Miles Laboratories, Elkhart, Ind., U.S.A.) (Johnson et al., 1978) . When chloroquine inhibition was experimentally reversed, the culture medium was removed after 12 h of infection, the cells washed with HBSS, and fresh F-12 medium (without chloroquine) was added. Cells were reincubated for 12 h at 39 °C and indirect immunofluorescence was carried out as described above.
Radiolabelling infected cells. To determine virus protein synthesis, N-18 cells (2 × 106 cells/tube) were infected with ts G31 (III) as described in the virus growth assay, and labelling medium (Hughes et al.,1979 b) and 5 pg/mt actinomycin D (Sigma)were added. The infected cells were then incubated at 39 °C and chloroquine (50 ~tg/ml) was added to cells either 1 h before infection or 1 h or 2 h post-infection. At 6 h post-infection 100 pCi/ml [35S]methionine (985 Ci/rnmol, New England Nuclear) in labelling medium was added with actinomycin D and chloroquine, and the cells were reincubated at 39 °C for 15 min. After incubation with [35S]methionine, the cultures were placed in ice, lysed in RSB (10 mu-Tris-HC1 pH 7.4, 10 mM-NaC1, 1-5 mM-MgC12) containing 1% Nonidet P40 (NP40; Bethesda Research Laboratories, Rockville, Md., U.S.A.) for 10 min at 0 °C. Nuclei were removed by centrifugation at 2000 g for 6 min, and the proteins were precipitated with 9 vol. acetone at --20 °C. The proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE; Laemmli, 1970) , identified by autoradiography and quantified by microdensitometry with a Joyce-Loebl densitometer. Galactose incorporation into glycoproteins was measured in VSV-infected N-18 cells essentially as described for protein synthesis assays except that the cells were incubated and labelled in F-12 medium, and no actinomycin D was used. At 6 h post-infection, 100 pCi/ml [3H]galactose (14.2 Ci/mmol, New England Nuclear) was added and the cells were reincubated at 39 °C for 30 min. The cultures were then put into ice, washed with HBSS, lysed with RSB and 1% NP40, the nuclei removed and the glycoprotein precipitated with acetone (Hughes et al., 1979b) . The precipitates were resuspended and electrophoresed on 8% SDS-polyacrylamide cylindrical gels (110 × 5 mm) and frozen at -80 °C. Slices (1 mm) were placed in Nuclear Chicago tissue solubilizer in RPI scintillator (Research Products International Corp., Elk Grove Village, Ill., U.S.A.) and radioactivity was determined (Hughes et al., 1979 b) .
Detecting the VSV G protein with radiolabelled IgG. Purified IgG (200/tg), prepared against the VSV G protein, was treated with chloramine T as described by Krause & McCarty (1962) . The specific activity of the resulting antibody fraction was 3.4 × 1012 ct/min/g. N-18 cells (2 × 105 cells) were infected with ts G31 (III) as described for the virus growth assay, and 50 ~tg/ml chloroquine was added 1 h or 2 h post-infection. At 24 h post-infection 2 × 103 cells were removed from a culture, placed in a tube with 2 ~tg radiolabelled IgG and incubated for 15 min at 0 °C. The cells were washed to remove unbound IgG, and the bound radioactivity was measured by scintillation spectrometry. Non-specific binding to uninfected cells was determined in the same manner, and the non-specific binding was subtracted from the total antibody bound to infected cells. G Protein present on the cell surface was also measured. All antibody binding assays were performed in triplicate and are reported as the average (_+ standard error of the mean).
RESULTS

Chloroquine inhibition of VSV-induced cell fusion
In the absence of chloroquine, tsG31 (III)-infected N-18 cells incubated at 39 °C (non-permissive for virus replication) undergo extensive cell fusion (Hughes et aL, 1979 a) . By 24 h post-infection, 90 % of the cells had fused and the resulting polykaryocytes continued to fuse, to yield an average of 14 nuclei per polykaryocyte (Table 1) . When chloroquine (50 /~g/ml) was added to the N-18 cells 1 h before the infection with ts G31 (III) no cell fusion was observed. As chloroquine has been reported to inhibit VSV uncoating (Miller & Lenard, '1980) , the ability of the drug [when added to cells before the ts G31 (III)] to inhibit cell-cell fusion might be expected. However, when chloroquine was added 1 h after infection, a subsequent incubation of the cells at 39 °C led to only 20% cell fusion 24 h post-infection and only two nuclei were present in the resulting polykaryocytes (Table 1) . Adding chloroquine 2 h post-infection led to 70% cell fusion at 24 h post-infection, although the subsequent fusion of polykaryocytes was sharply reduced as there were only four nuclei per polykaryocyte (Table 1) . Since 13 fusion events would be required to produce polykaryocytes with 14 nuclei (non-chloroquine-treated controls), polykaryocytes with only four nuclei (three fusion events) represent a 77% inhibition of fusion (Table 1) . By similar calculations, inhibition of cell fusion when chloroquine was added 1 h post-infection was 92%.
Virus protein synthesis after ehloroquine treatment
Since virus uncoating would have occurred when chloroquine was added 1 h or 2 h post-infection (Miller & Lenard, 1980) , the inhibition of cell fusion may have resulted from the drug inhibiting virus protein synthesis. Therefore, the incorporation of [35S]methionine into virus proteins in the presence of chloroquine was measured at 6 h post-infection. Pretreatment of N-18 cells with 50 pg/ml chloroquine 1 h before their infection with ts G31 (III) completely inhibited VSV protein synthesis (Fig. 1 ) which is consistent with the suggestion that chloroquine can inhibit virion uncoating or other stages of early virus infection. Even though cell fusion was significantly reduced when chloroquine was added 1 h or 2 h post-infection (Table 1) , VSV protein synthesis was 90% and 100% of the non-treated controls respectively (Fig. 1) . Therefore, the inhibition of cell fusion by chloroquine could not be explained by an inhibition of either early events associated with infection or subsequent virus-directed protein synthesis. t Extent of cell fusion was determined by light microscopy as the percentage of nuclei in polykaryocytes compared with total nuclei present.
$ Number of fusion events represents the number of cell-cell fusions required to produce a polykaryocyte with the average number of nuclei observed for each treatment; inhibition of cell fusion was calculated from those values.
Effect of chloroquine on VSV assembly
Since virus proteins were efficiently synthesized in N-18 cells when chloroquine was added either 1 h or 2 h post-infection, we measured the yield of infectious virus to determine if later events associated with VSV replication were inhibited by the drug. To circumvent the inhibition of VSV maturation that would be associated with VSV ts mutants incubated at 39 °C, N-18 cells were infected with wt VSV. When cells were infected with wt VSV and 50 pg/ml chloroquine was added 1 h or 2 h post-infection, no detectable infectious virions were found at 12 h or 24 h post-infection. This was an interesting observation since virus protein 
h post-infection (h) No treatment Pretreatment post-infection post infection
12 2 x 106 <10 <10 <'10 24 1.6 × 10 6 <'10 <'10 <'10 * N-18 cells (2 x 105 cells/tube) were infected with wt VSV at an m.o.i of 10, adsorbed for 30 min at 25 °C, washed, and incubated at 39 °C for 12 or 24 h. The N-18 cells were either pretreated for 1 h before infection with 50/~g/ml chloroquine, or treated 1 h or 2 h post-infection with 50 pg/ml chloroquine, or were untreated throughout incubation. The p.f.u, were determined as described by Holland & McLaren (1959) and expressed as the increase in virus titre over the zero time-point. synthesis is not inhibited by chloroquine when added 1 h or 2 h post-infection, and yet the maturation of infectious virions was completely blocked. Clearly, chloroquine inhibited the later stages of VSV assembly and/or release from the infected N-18 cells. Consistent with the absence of virus protein synthesis in N-18 cells treated with chloroquine I h before infection, no infectious virus was released from pretreated cells ( Table 2) .
Detection of the VS V glycoprotein on the surfaces of chloroquine-treated cells
Cell fusion, mediated by ts G31 (III) at 39 °C, requires the appearance of the VSV G protein at the cell surface (Hughes et al., 1979 a) . Therefore, adding chloroquine after VSV infection could have blocked maturation of the G protein and led to inhibition of both cell fusion and the yield of infectious virions. To measure the virus G protein at the infected cell surface, N-18 cells were fixed with formaldehyde and observed by indirect immunofluorescence. N-18 cells infected with ts G31 (III) and incubated at 39 °C for 24 h in the absence of chloroquine showed high fluorescence compared with that of uninfected cells (Fig.  2) . Cells infected with ts G31 (III) and treated with 50 flg/ml chloroquine 1 h or 2 h post-infection had extremely low fluorescence at 24 h post-infection, similar to that of uninfected cells (Fig. 3) . Since fusion, although at a reduced level, occurred in the cells treated with chloroquine 1 h or 2 h post-infection, G protein was most likely to be found at the cell surface, but at concentrations too low to be detected by indirect immunofluorescence. A more sensitive assay was then used to assess the quantity of G protein on the cell surface of ts G31 (III)-infected N-18 cells treated with chloroquine at 1 h or 2 h post-infection. Rabbit anti-G IgG labelled with radioactive iodine was used to measure G protein at the cell surface 24 h post-infection with ts G31 (III) using cells not treated with chloroquine, or cells to which chloroquine was added 1 h or 2 h post-infection (Table 3) . Antibody binding could not be detected above background levels on the surface of cells 24 h post-infection when chloroquine was added 1 h after the ts G31 (Ill). However, when chloroquine was added 2 h post-infection, we measured approx. 16 % of the G protein found on infected untreated cells. Consistent with this measurement was our observation that at 2 h post-infection the N-18 cell, in the absence of chloroquine, also had approx. 16 % of the G protein measured at 24 h post-infection. Therefore, adding chloroquine resulted in rapid cessation of G protein maturation to the cell surface, and the limited fusion observed in the presence of the drug correlated with the reduced quantities of G protein at the cell surface.
VS V glycoprotein inside ehloroquine-treated cells
The similar mobility of the G protein in SDS-polyacrylamide gels whether or not cells had been treated with chloroquine ( Fig. 1) indicated that the virus glycoprotein had an apparent mol. wt. of 69 000. The G protein, therefore, was apparently being glycosylated (Zilberstein et al., 1980) in the presence o f chloroquine, which m a y have been inhibiting migration o f the molecules to the cell surface. Fixation o f the infected cells with acetone : m e t h a n o l (2 : 1, v/v), which allows antibody to penetrate into the cell, followed by indirect i m m u n o f l u o r e s c e n c e confirmed that the G protein was present in chloroquine-treated cells since the level o f fluorescence was similar to that in untreated but infected cells (Fig. 4) . The G protein was therefore synthesized in chloroquine-treated cells, apparently glycosylated, m a t u r e d to an antigenically recognizable form, but not expressed at the cell surface. 
Reversal of ehloroquine inhibition of the VSV glyeoprotein expression at the N-18 cell surface membrane
If, in the presence of chloroquine, the G protein was matured but inhibited only in its migration to the cell surface, we reasoned that a subsequent blocking of further glycosylation when chloroquine was removed might not prevent an accumulation of the glycoprotein at the N-18 cell surface. To test that possibility, cells were infected with ts G31 (III) and 50 #g/ml chloroquine was added at 1 h post-infection, incubated at 39 °C, and at 12 h post-infection fresh medium (without chloroquine) was added. Continued incubation at 39 °C led to 80% of the cell fusion measured with untreated infected cells and an increase to an average of approx. 10 nuclei per polykaryocyte. When tunicamycin, an inhibitor of glycosylation (Tkacq & Lampen, 1975) , was added to block further glycosylation during reincubation, cell fusion reached 80% with 10 nuclei per polykaryocyte by 24 h. Consistent with cell fusion, the G protein at the cell surface was readily detected by immunofluorescence assays of formaldehyde-fixed reversed (Fig. 5 a) and reversed with tunicamycin-treated cells (Fig. 5 b) . In contrast, cells incubated with tunicamycin throughout the infection did not fuse and did not react with the anti-G IgG in fluorescence assays. Consistent with inhibition of G protein maturation late in its synthesis, no difference in the incorporation of galactose, one of the sugars in the mature oligosaccharide moiety of the G protein (Hunt et al., 1978) , into the glycoprotein could be observed between chloroquine-treated and untreated N-18 cells infected with ts G3 i (III) and incubated at 39 °C (data not shown).
DISCUSSION
An interesting relationship exists between ts G31 (III) VSV-induced neuroblastoma cell fusion and the neuropathology that results from intracerebral injection of mice with this virus. Within days after injection with ts G31 (III) a marked status spongiosus is evident (Dal Canto et al., 1976) . The mutant ts G31 (I!I) also induced cell fusion in culture. Cell fusion in culture is limited to nervous system-derived cells and to incubation conditions non-permissive for infectious virion maturation (Hughes et al., 1979 a; Dille et al., 1982) . Status spongiosus is a common neuropathological feature of several slow virus diseases including kuru, Creutzfeldt-Jakob disease and scrapie (Lampert et al., 1972) . Although perhaps circumstantial, cell fusion has been observed in the CNS of kuru victims (Klatzo et al., 1959) as well as in vitro with N-18 neuroblastoma cells exposed to brain homogenates from victims of slow virus diseases (Kidson et al., 1978; Moreau-Dubois et al., 1979) .
Several lines of evidence showed that chloroquine inhibited neuroblastoma cell fusion without interfering with VSV protein synthesis. (i) The virus G protein, which is responsible for initiating cell fusion, migrated on SDS-polyacrylamide gels at a mol. wt. of 69 000 whether or not the drug was present (Fig. 1) ; (ii) with chloroquine removed, tunicamycin was unable to prevent the G protein from maturing to the infected cell surface (Fig. 5) ; (iii) incorporation of galactose into the glycoprotein in the presence of chloroquine demonstrated continued glycosylation of the G protein polypeptide. Indirect immunofluorescence studies confirmed that, although the G protein was in the infected cell in an antigenically distinguishable form (Fig. 4) , chloroquine inhibited its maturation or migration to the cell surface (Table 3) . Ball (1977) has shown that VSV protein synthesis is initiated quickly after infection and mature G protein can be detected at the cell surface 20 to 30 min after the polypeptide is translated (Atkinson et al., 1976; Knipe et al., 1977) . Rapid maturation of the G protein after infection explains why we observed at least minimal cell fusion when chloroquine was added 1 or 2 h post-infection. It was already known that continued G protein synthesis and maturation are required for continued neuroblastoma cell fusion (Hughes et al., 1979a) . These facts were supported by the observation that continued G protein expression at the cell surface was blocked when chloroquine was added 2 h post-infection. The use of iodinated anti-G IgG permitted us to quantify the glycoprotein at the cell surface, and addition of chloroquine at 2 h post-infection led to a complete inhibition of G protein expression.
Previous studies on the ability of chloroquine to inhibit enveloped virus replication focused on the drug's ability to interfere with initiation of infection (Coombs et al., 1981; Durand et al., 1971; Helenius et al., 1980; Miller & Lenard, 1980) . Helenius et al. (1980) demonstrated that Semliki Forest virus entered BHK cells by endocytosis and was sequestered in cytoplasmic vacuoles and lysosomes. If lysosomal enzyme activities were inhibited by chloroquine, uncoating of the virus could not have proceeded and the viruses would have accumulated in lysosomes. Our results support a similar series of events associated with the initial infection of N-18 neuroblastoma cells with VSV. Adding chloroquine before infection negated subsequent VSV protein synthesis (Fig. 1) , and infectious viruses were not released (Table 2 ). This contrasts with VSV infection of BHK cells where virus entry has been suggested to involve virus envelope-cell membrane fusion (Coombs et al., 1981) . The reduced yield of infectious VSV virions observed in the presence of chloroquine (Coombs et al., 1981) may have resulted from an inhibition of G protein expression at the cell surface, which is necessary for infectious virus replication.
Our results have shown that chloroquine has multiple effects on VSV replication. When added prior to infection chloroquine inhibited the initial stages of virus replication and no VSV proteins or infectious virions were produced. However, when chloroquine was added 1 or 2 h post-infection virus protein synthesis was not inhibited, although the expression of the G protein at the cell surface was significantly reduced and virions were not released. Chloroquine inhibition of these stages of VSV maturation was readily reversed since removal of the drug resulted in G protein expression and subsequent cell fusion. In addition, the chloroquine block in the late stage of virion maturation is after the tunicamycin-sensitive step.
